surmount-1 tirzepatide weight loss nondiabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes GLP-1 Agonists For Obesity In

Common Side Effects and Considerations Common side effects include mild-to-moderate gastrointestinal symptoms

As weve seen in our own program over the last year, the benefits of these medications far outweigh the risks which is why we understand and support patients who feel like they dont want to quit the medications cold turkey. Keep in mind that the FDA has approved the medications for indefinite use

Ethical Approval The study protocol was approved by local institutional review boards and adhered to the principles outlined in the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines

We know that understanding potential side effects is essential

Is Tirzepatide Hair Loss Permanent

[17] [18] Therefore, the combination should not be used with the expectation of enhanced cardiovascular protection